14.3 C
New York
Tuesday, March 21, 2023

Insights Into Alnylam Pharmaceuticals Inc. (ALNY) Exposure By Institutions

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. After-hours trades for Alnylam Pharmaceuticals Inc. (ALNY) shows that investor sentiment remained same, with the stock’s consolidated last price remained same to $225.40. The Alnylam Pharmaceuticals Inc. has recorded 139,509 volume in the after hours trading session. Most recently, Yahoo Finance reported about the stock as it publicized that Alnylam Announces Preliminary* Fourth Quarter and Full Year 2022 Global Net Product Revenues and Provides Additional Updates.

From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio

The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.

Get our free report, "Top 5 AI Stocks to Buy for 2023".


Stocks Info

Alnylam Pharmaceuticals Inc. is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $225.40 and fluctuated between $231.48 as its day high and $224.25 as its day low. The current market capitalization of Alnylam Pharmaceuticals Inc. is $27.76B. A total of 0.61 million shares were traded on the day, compared to an average of 747.74K shares.

Insider Activity

Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, ALNY has seen 5 BUY and 2 SELL insider trades, representing the acquisition of 27,579 and the disposition of 23,824 shares. Over the last 12 months, there were 23 BUYs and 48 SELLs from insiders. Insiders purchased 163,818 shares during that period but sold 133,343.

In the most recent transaction, Ausiello Dennis A sold 22,500 shares of ALNY for 220.00 per share on Nov 21. After the transaction, the Director now owns 0 company shares. In a previous transaction on Aug 15, SHARP PHILLIP A sold 33,670 shares at 230.49 per share. ALNY shares that Director owns now total 0.

Among the insiders who sold shares, Tanguler Tolga disposed of 1,841 shares on Aug 05 at a per-share price of $218.16. This resulted in the EVP, Chief Commercial Officer holding 0 shares of ALNY after the transaction. In another insider transaction, Tanguler Tolga sold 1,754 shares at $210.00 per share on Aug 03. Company shares held by the EVP, Chief Commercial Officer now total 3,629.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for ALNY in the last 3 months, the mean price target is $249.41 with high estimates of $415.00 and low estimates of $143.00. In terms of 52-week highs and lows, ALNY has a high of $242.97 and a low of $117.58.

As of this writing, ALNY has an earnings estimate of -$1.67 per share for the current quarter. EPS was calculated based on a consensus of 17 estimates, with a high estimate of $1.71 per share and a lower estimate of -$2.68. The company reported an EPS of -$2.29 in the last quarter, which was -40.50% lower than expectations of -$1.63.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 26 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ALNY is Sell with a score of 4.30. A total of 16 analysts rated the stock as Buy while 1 rated it as Overweight while 9 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles